Liu HC - Search Results

1

Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.

Lu S, Liu HC, Chen YD, Yuan HL, Sun SL, Gao YP, Yang P, Zhang L, Lu T. Lu S, et al. Among authors: liu hc. Int J Mol Sci. 2011;12(12):8713-39. doi: 10.3390/ijms12128713. Epub 2011 Dec 1. Int J Mol Sci. 2011. PMID: 22272100 Free PMC article.

2

Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors.

Chen XM, Lu T, Lu S, Li HF, Yuan HL, Ran T, Liu HC, Chen YD. Chen XM, et al. Among authors: liu hc. J Mol Model. 2010 Jul;16(7):1195-204. doi: 10.1007/s00894-009-0630-y. Epub 2009 Dec 18. J Mol Model. 2010. PMID: 20020310

3

Recent advances in the research and development of B-Raf inhibitors.

Li HF, Chen Y, Rao SS, Chen XM, Liu HC, Qin JH, Tang WF, Yue-Wang, Zhou X, Lu T. Li HF, et al. Among authors: liu hc. Curr Med Chem. 2010;17(16):1618-34. doi: 10.2174/092986710791111242. Curr Med Chem. 2010. PMID: 20345352 Review.

4

Novel strategy for three-dimensional fragment-based lead discovery.

Yuan H, Lu T, Ran T, Liu H, Lu S, Tai W, Leng Y, Zhang W, Wang J, Chen Y. Yuan H, et al. J Chem Inf Model. 2011 Apr 25;51(4):959-74. doi: 10.1021/ci200003c. Epub 2011 Mar 25. J Chem Inf Model. 2011. PMID: 21438547

5

A selectivity study on mTOR/PI3Kα inhibitors by homology modeling and 3D-QSAR.

Ran T, Lu T, Yuan H, Liu H, Wang J, Zhang W, Leng Y, Lin G, Zhuang S, Chen Y. Ran T, et al. J Mol Model. 2012 Jan;18(1):171-86. doi: 10.1007/s00894-011-1034-3. Epub 2011 Apr 27. J Mol Model. 2012. PMID: 21523553

6

Pharmacophore modeling and virtual screening studies to identify new c-Met inhibitors.

Tai W, Lu T, Yuan H, Wang F, Liu H, Lu S, Leng Y, Zhang W, Jiang Y, Chen Y. Tai W, et al. J Mol Model. 2012 Jul;18(7):3087-100. doi: 10.1007/s00894-011-1328-5. Epub 2011 Dec 28. J Mol Model. 2012. PMID: 22203475

7

Identification of novel polo-like kinase 1 inhibitors by a hybrid virtual screening.

Lu S, Sun SL, Liu HC, Chen YD, Yuan HL, Gao YP, Yang P, Lu T. Lu S, et al. Among authors: liu hc. Chem Biol Drug Des. 2012 Aug;80(2):328-39. doi: 10.1111/j.1747-0285.2012.01412.x. Epub 2012 Jun 8. Chem Biol Drug Des. 2012. PMID: 22583481

8

Design, synthesis and biological evaluation of β-carboline derivatives as novel inhibitors targeting B-Raf kinase.

Xin B, Tang W, Wang Y, Lin G, Liu H, Jiao Y, Zhu Y, Yuan H, Chen Y, Lu T. Xin B, et al. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4783-6. doi: 10.1016/j.bmcl.2012.05.053. Epub 2012 May 24. Bioorg Med Chem Lett. 2012. PMID: 22704238

9

De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein-ligand interaction fingerprint, and ADMET prediction.

Zhang Y, Liu H, Jiao Y, Yuan H, Wang F, Lu S, Yao S, Ke Z, Tai W, Jiang Y, Chen Y, Lu T. Zhang Y, et al. Mol Divers. 2012 Nov;16(4):787-802. doi: 10.1007/s11030-012-9405-y. Epub 2012 Oct 23. Mol Divers. 2012. PMID: 23090418

10

[Targeting the substrate binding domain of polo-like kinase 1: advances in the study of PBD1 inhibitors].

Zhang L, Cao YH, Lu S, Sun SL, Liu HC, Lu T. Zhang L, et al. Among authors: liu hc. Yao Xue Xue Bao. 2013 Mar;48(3):315-24. Yao Xue Xue Bao. 2013. PMID: 23724641 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,995 results

Search Page

Filters